Expert Pitch
Florida State University

FSU expert available to comment on effectiveness of flu vaccine

17-Feb-2020 9:00 AM EST, by Florida State University

By: Bill Wellock | Published: | 3:35 pm | SHARE: Share on FacebookTweet

Newswise — As an outbreak of a new coronavirus makes headlines across the world, another more common infectious disease is spreading across the United States and beyond — the flu.

About 8 percent of the U.S. population gets sick from the flu each season, according to the Centers for Disease Control and Prevention. Although anyone can get sick, people 65 years and older, children younger than 5, pregnant women and people with medical conditions are at greater risk of serious complications.

Dr. Christie Alexander, an associate professor at the Florida State University College of Medicine and president of the Florida Academy of Family Physicians, is available to explain how scientists develop each year’s flu vaccine, why its effectiveness varies and whether it’s still worth getting a flu shot in February.

How does the development process for each year’s flu vaccine work?
Development starts right around the end of the previous year’s flu season, and it’s based on that year’s flu season. Scientists try to develop the vaccine based on that season, looking back to see what the rates of the various flu strains were and then developing the flu vaccine according to that, trying to anticipate what the next flu season will look like.

Can you talk about the different strains?
There’s influenza A and influenza B. The flu shot is trying to prevent against two strains of A and two strains of B. Those strains mutate every year, so scientists try to target the mutations as best they can and create the vaccine based on what those strains looked like that year.

Why is the vaccine sometimes more or less effective?
This is because the strains mutate so quickly and so readily. Even after scientists develop the shot and we start to administer it, those strains can change again. Once the flu shot is developed, you can’t recreate it, so the hope is that scientists are able to correctly predict any possible mutations for the next year in order to gain the most protection from the shot.

Some experts have said there may be a “mismatch” between the vaccine and the strains this year. What does that mean?
That gets back to mutation. We have the two strains of influenza A and the two strains of influenza B, and if one of those four strains starts to mutate, then the shot will no longer match the strains. So it might hit three of the four really well, but if the fourth starts to mutate, you’ll see a resurgence from that strain. That’s what the term “mismatch” means. It doesn’t happen every year. In fact, over time, the shot has been 40 to 60 percent effective, which translates into the prevention of literally millions of illnesses and flu-related doctor’s visits each year. For example, based on information from the CDC, during the 2017-2018 flu season, the vaccination prevented an estimated 6.2 million influenza illnesses, 3.2 million influenza-associated medical visits, 91,000 influenza-associated hospitalizations and 5,700 influenza-associated deaths.

How effective is this year’s vaccine?
We can’t know final numbers until flu season is over because the numbers include how many people got the shot, how many cases of the flu we saw, which strains of the flu they were, how many people were hospitalized — those types of things. Right now, it looks like it is on track with previous years, but it’s hard to say. The most recent data from the CDC shows most cases are influenza B this year, but this alone does not predict how effective the shot has been.

Right now, it’s February. Should you still get a flu shot if you haven’t gotten one?
Absolutely. The flu season usually goes from October all the way through April, sometimes even May. We see a bimodal uptick with a rise in cases in December and a rise in cases in February. Therefore, we recommend continuing to get the flu shot to not only avoid getting the flu, but to avoid complications from the flu, such as hospitalizations, influenza-associated illnesses like pneumonia or even death. So the short answer is, “Yes! Get your flu shot!”




Filters close

Showing results

110 of 5636
Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:00 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.

Released: 13-May-2021 9:00 AM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET
Newswise

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 13-May-2021 8:00 AM EDT
Dental procedures during pandemic are no riskier than a drink of water
Ohio State University

A new study’s findings dispel the misconception that patients and providers are at high risk of catching COVID-19 at the dentist’s office.

Newswise:Video Embedded lung-damage-not-the-culprit-for-post-covid-exercise-limitations
VIDEO
Released: 13-May-2021 7:00 AM EDT
Lung Damage Not the Culprit for Post-COVID Exercise Limitations
American Physiological Society (APS)

A new study suggests the lungs may not be the main factor that reduce exercise ability in people recovering from severe COVID-19. Anemia and muscle dysfunction also play a role. The study is published ahead of print in the Journal of Applied Physiology. It was chosen as an APSselect article for May.


Showing results

110 of 5636

close
2.77781